Shearman & Sterling represented Morgan Stanley & Co. LLC, Credit Suisse (USA) LLC and J.P. Morgan LLC, as joint bookrunning managers, and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Fifth Third Securities, Inc., U.S. Bancorp Investments, Inc., The Governor and Company of the Bank of Ireland, TD Securities (USA) LLC and The Williams Capital Group, L.P. in connection with the private placement, pursuant to Rule 144A and Regulation S, of $1.05 billion aggregate principal amount of its 4.375% Senior Notes due 2019 and $750 million aggregate principal amount of its 4.875% Senior Notes due 2021. Forest Laboratories used the net proceeds from the notes offering, together with cash on hand, to fund the acquisition of Aptalis Holdings, Inc.
The Shearman & Sterling team included partners Michael Benjamin (New York-Capital Markets), Michael Steinberg (New York-Finance), Maura O’Sullivan (New York-Finance) and Samuel Waxman (New York-Intellectual Property Transactions) and associates Merritt Johnson (New York-Capital Markets), Ethan Siller (Toronto-Capital Markets), Christopher Tomlinson (New York-Corporate), Dan Smith (New York-Tax), Corey Reis (New York-Finance), Michael Jokic (New York-Intellectual Property Transactions), Joshua Steinberger (New York-Intellectual Property Transactions), Benjamin Petersen (New York-Intellectual Property Transactions), Jacob Bitton (New York-Corporate) and Jenny Ding (New York-Corporate).
